Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biosource International -- Ignore unavailable to you. Want to Upgrade?

To: milton who wrote (341)	12/3/1997 8:41:00 AM
From: Joe Dancy	Respond to of 696

I have no idea Milton - other than maybe selling for tax reasons - for the price weakness. Did a literature search last night to see if any articles mentioned BIOI or industry issues that would account for price weakness, and there were none. If the price weakness persists for the next few days I may do some tax selling and replace the sold shares with BIOI - even if we have a short term financial disappointment we should do well unless we are blindsided here by something totally unexpected. Best - Joe

To: milton who wrote (341)	12/3/1997 8:45:00 AM
From: Steven Dopp	Respond to of 696

I'm just guessing but maybe the drop in price has something to do with Red Chip Review. I've noticed at least one other stock touted by RCR that dropped after a prolonged period of promotion oby RCR. Coud it be that demand for the stock was increased by the knowledge RCR was touting it? When that demand was sated, the price sagged. I'm thinking of Synthetec (NZYM) as performing in this fashion. I noticed that volume seems to be dropping. Still, no news, no change in the fundamental prospects for BIOIso this could be a buying opportunity.

To: milton who wrote (341)	12/3/1997 8:18:00 PM
From: Steve Lokness	Read Replies (1) \| Respond to of 696

Joe; What is going on with BIOI is going on with just about the entire biotech sector. Good news seems to only hold a stock from dropping while bad news or no news seems to send these stocks into a tailspin. IMO, it is a jittery market that is heading to the big well known co's. I look at it as a buying opportunity and think of holding the stocks for long term appreciation. My problem is that there is so many biotechs "on sale" that I don't have enough money to go around. Good Investing! Steve